Once weekly, smaller needle, no nodules and look at where it is indicated. "The FDA said that the safety and efficacy of Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, had been studied in 3,342 type 2 diabetics. The drug can be given as monotherapy or in combination with other diabetes drugs including metformin, sulfonylurea, thiazolidinediones, and prandial insulin" Can be used with PRANDIAL INSULIN because it is known that QW GLP1's have more effect on fasting than PPG. Which is why BYD has no indication with basal and simply does not work for PPG. Lilly's indications for Trulicity will reinforce to physicians the limitations of BYD and how they have be misled to believe it is interchangeable with Byetta and Victoza.
"In its latest results, presented at the American Diabetes Association conference, dulaglutide proved itself noninferior to Novo Nordisk's blockbuster Victoza--the $2 billion-a-year standard-bearer among GLP-1 therapies. That's the first time a once-weekly GLP-1 agent has ever equaled a daily one in a Phase III trial, Lilly said--including GlaxoSmithKline's recently approved Tanzeum. And it will be at the heart of Lilly's campaign to sell this treatment as a more convenient alternative to Victoza." Non-inferior to Victoza and INDICATED with prandial insulin. Oh how will AZ spin this? The Bydureon pen is good for people with dexterity issues and who else?
AZ will look far more unethical when Lilly is able to show how weekly GLP1 works more on fasting than PPG and how theirs can be used with prandial insulin. This comes after AZ reps have been telling doctors for the past year that all Byetta and Victoza patients can be switched to Bydureon. AZ did this knowing you cannot ask for switches unless the drugs have equivalent indications. Bydureon does not have an indication with basal insulin. Lilly's indication with prandial will put a spotlight on how differently the daily and weekly GLP1's work.
Amylin's name should have been SCAMlin. Biggest scam in pharma history and the scam continues with ESS.
Screw you, I have taken it for the past 5 years to help block the absorption of carbs. It works and I have been able to keep my toes and eye sight, thank you very much. T1D
So true, I worked for Amylin. The company never turned a profit. They were desperate to unload it right when Bydureon came out because they knew the shortcomings of the drug would be more obvious as time went on. A big stock scam AZ and BMS were the ones that got screwed.
Because there disease has gone wild and uncontrolled because they most likely miss doses of there daily GLP-1.
